Patients given the malaria drug touted by President Donald Trump as a potential treatment for COVID-19 did not improve significantly over those who did not, according to two new studies published in the medical journal BMJ on Thursday.
from Reuters: Top News https://reut.rs/2Z6pmST
via IFTTT
from Reuters: Top News https://reut.rs/2Z6pmST
via IFTTT